GAT211

Code: SML1926-5MG D2-231

Biochem/physiol Actions

GAT211 is a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling. GAT211 was found to amplify the therapeutic effect of endocanna...


read more

Your Price
€127.40 5MG
€156.70 inc. VAT
REQUEST

Biochem/physiol Actions

GAT211 is a positive allosteric modulator (PAM) of cannabinoid CB1 receptor signaling. GAT211 was found to amplify the therapeutic effect of endocannabinoids without the negative side effects of psychoactivity or tolerance. GAT211 caused a CB1-dependent suppression of paclitaxel-induced mechanical and cold allodynia with no sign of tolerance over 19 days of administration.

assay≥98% (HPLC)
colorwhite to beige
formpowder
Quality Level100
SMILES stringO=[N+]([O-])CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3)NC4=CC=CC=C42
solubilityDMSO: 10 mg/mL, clear
storage temp.2-8°C
Cas Number102704-40-5
This product has met the following criteria to qualify for the following awards:



PROCEED TO CHECKOUT

HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.